Literature DB >> 12118154

Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia.

H G Bernstein1, D Krell, K H Braunewell, B Baumann, E D Gundelfinger, S Diekmann, P Danos, B Bogerts.   

Abstract

There is growing interest in the cerebellum as a site of neuropathological changes in schizophrenia. Reports showing that schizophrenics have higher nitric oxide synthase (NOS) activity and MAPKinase levels in the vermis, point to possible aberrations in the cerebellar signal transduction of schizophrenics. It has been speculated that Ca(2+)-dependent extracellular to intracellular signal transduction may be disrupted in the cerebellum of schizophrenics. We decided to test this hypothesis by studying the nitrergic system and markers of the Ca(2+)-triggered signal cascade in the cerebellum of schizophrenics, depressives and controls. The cellular distribution of two calcium sensor proteins (VILIP-1 and VILIP-3) and of neuronal NOS immunoreactivity was studied morphometrically in the flocculonodulus, the inferior vermis and the dentate nucleus of 9 schizophrenics, 7 depressive patients and 9 matched controls. In comparison to controls and depressed patients there were fewer Nissl-stained neurons in the dentate nucleus of schizophrenics. The number of NOS-expressing Purkinje neurons was however strongly increased. In the flocculonodulus and the vermis no differences between the groups were found with regard to the density of Nissl-stained Purkinje cells. The number of NOS-expressing Purkinje neurons was increased in schizophrenics, however. No differences between schizophrenics, depressives and controls were found in the number of VILIP-1 immunoreactive dentate nucleus neurons and VILIP-3 immunoreactive vermal and flocculonodular Purkinje cells. Our data provide further histochemical evidence in favor of structural abnormalities in discrete cerebellar regions of schizophrenics. They confirm and extend earlier reports of increased cerebellar NOS immunoreactivity in schizophrenia and point to possible neurodevelopmental disturbances. Our failure to show an altered expression of two calcium sensor proteins possibly points to a less important role of calcium signaling in cerebellar pathology of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12118154     DOI: 10.1023/a:1016520932139

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  12 in total

Review 1.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

Review 2.  Stereological approaches to identifying neuropathology in psychosis.

Authors:  Karl-Anton Dorph-Petersen; David A Lewis
Journal:  Biol Psychiatry       Date:  2010-08-01       Impact factor: 13.382

3.  Information processing deficits and nitric oxide signalling in the phencyclidine model of schizophrenia.

Authors:  Erik Pålsson; John Lowry; Daniel Klamer
Journal:  Psychopharmacology (Berl)       Date:  2010-08-28       Impact factor: 4.530

4.  Involvement of anti-inflammatory, antioxidant, and BDNF up-regulating properties in the antipsychotic-like effect of the essential oil of Alpinia zerumbet in mice: a comparative study with olanzapine.

Authors:  Fernanda Yvelize Ramos de Araújo; Adriano José Maia Chaves Filho; Adriana Mary Nunes; Gersilene Valente de Oliveira; Patrícia Xavier Lima Gomes; Germana Silva Vasconcelos; Jaqueline Carletti; Manoel Odorico de Moraes; Maria Elisabete de Moraes; Silvânia Maria Mendes Vasconcelos; Francisca Cléa Florenço de Sousa; David Freitas de Lucena; Danielle S Macedo
Journal:  Metab Brain Dis       Date:  2021-09-07       Impact factor: 3.584

5.  Taurine, an essential β-amino acid insulates against ketamine-induced experimental psychosis by enhancement of cholinergic neurotransmission, inhibition of oxidative/nitrergic imbalances, and suppression of COX-2/iNOS immunoreactions in mice.

Authors:  Benneth Ben-Azu; Olusegun G Adebayo; Thiophilus Aghogho Jarikre; Mega O Oyovwi; Kesiena Emmanuel Edje; Itivere Adrian Omogbiya; Anthony T Eduviere; Emuesiri Goodies Moke; Bienose S Chijioke; Onyebuchi S Odili; Osemudiame P Omondiabge; Aghogho Oyovbaire; Daniel T Esuku; Esther O Ozah; Kelvin Japhet
Journal:  Metab Brain Dis       Date:  2022-09-03       Impact factor: 3.655

6.  No change in neuron numbers in the dentate nucleus of patients with schizophrenia estimated with a new stereological method--the smooth fractionator.

Authors:  B B Andersen; K Fabricius; H J G Gundersen; J Jelsing; A K Stark
Journal:  J Anat       Date:  2004-10       Impact factor: 2.610

Review 7.  The role of the extracellular signal-regulated kinase pathway in cerebellar abnormalities in schizophrenia.

Authors:  Svetlana V Kyosseva
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

8.  Grey and white matter proportional relationships in the cerebellar vermis altered in schizophrenia.

Authors:  Glenn Lawyer; Ragnar Nesvåg; Katarina Varnäs; Gaku Okugawa; Ingrid Agartz
Journal:  Cerebellum       Date:  2009-03       Impact factor: 3.847

Review 9.  Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects.

Authors:  Regina F Nasyrova; Dmitriy V Ivashchenko; Mikhail V Ivanov; Nikolay G Neznanov
Journal:  Front Physiol       Date:  2015-05-11       Impact factor: 4.566

Review 10.  Neuronal nitric oxide synthase expression in cerebellar mutant mice.

Authors:  Louise C Abbott; Sang-Soep Nahm
Journal:  Cerebellum       Date:  2004       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.